Skip to main content
. 2022 Oct 28;8:143. doi: 10.1038/s41531-022-00412-w

Table 2.

Heterogeneity in 12-month MDS-UPDRS subpart progression.

MDS-UPDRS I MDS-UPDRS II MDS-UPDRS III MDS-UPDRS Total
MDS-UPDRS I 100% 58% 53% 62%
MDS-UPDRS II - 100% 61% 71%
MDS-UPDRS III - - 100% 87%
MDS-UPDRS Total - - - 100%

Overlap across MDS-UPDRS subparts and Total progression status, as measured by Jaccard similarity. This matrix is symmetric thus lower diagonal values are excluded.